Veazey wins Travel Award and meets NIH Director
Friday, December 16, 2016
Ms. Veazey won a travel award from the Graduate Women in Science to attend the 2017 American Thoracic Society Meeting. She will present her work entitled “Epithelial PKD3 is a novel regulatory of anti-viral innate immunity”. In 2016, she was one of a handful of graduate students selected to have lunch with NIH Director Dr. Francis Collins during his visit to the University.
Chapman receives Lung Biology Pilot and Technology Development Fund Award
Tuesday, September 20, 2016
Dr. Chapman received a Lung Biology Pilot Project Award to explore how electric field stimulation impacts mucosal immunity using asthma models. Together with Dr. Georas and Dr. David Dean (Neonatology), the team also received a Technology Development Fund award from UR Ventures to develop the therapeutic potential of this exciting new technology.
Georas rotates off the Pulmonary and Allergy Drug Advisory Committee of the FDA
Thursday, September 1, 2016
Dr. Georas concluded a four-year stint as a member of the PADAC, advising the Food and Drug Administration on new drug applications for asthma and other diseases. During this time, new drugs for asthma were approved including mepolizumab, reslizumab, and Breo Ellipta.
Georas named Section Editor of Journal of Immunology
Wednesday, June 1, 2016
After serving two years as Associate Editor, Dr. Georas accepted a term as Section Editor of the Journal of Immunology, the flagship journal of the American Association of Immunologists. He is responsible for reviewing submitted manuscripts related to asthma and allergic airway inflammation.